These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24330082)

  • 21. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W; Su J; Xu S; Yan D
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of IGS1, ITS and D1/D2 regions in molecular identification of Trichosporon species and genotype of T. asahii in China].
    Xia ZK; Yang RY; Wang WL; Ao JH; Wang CM; Zhu H
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3145-8. PubMed ID: 19159600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Trichosporon spp. strains by sequencing D1/D2 region and sub-typing by sequencing ribosomal intergenic spacer region of ribosomal DNA.
    Zeng J; de Souza Motta CM; Fukushima K; Takizawa K; Magalhes OM; Neves RP; Nishimura K
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):655-8. PubMed ID: 19821104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
    Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-healing ulcer due to Trichosporon loubieri in an immunocompetent host and review of published reports.
    Rastogi V; Rudramurthy SM; Maheshwari M; Nirwan PS; Chakrabarti A; Batra S
    Mycopathologia; 2013 Aug; 176(1-2):107-11. PubMed ID: 23591623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological characteristics of medically important Trichosporon species.
    Li HM; Du HT; Liu W; Wan Z; Li RY
    Mycopathologia; 2005 Oct; 160(3):217-25. PubMed ID: 16205970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY; Chien JY; Hsueh PR
    Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
    Escribano P; Peláez T; Recio S; Bouza E; Guinea J
    Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
    Metin DY; Hilmioglu-Polat S; Hakim F; Inci R; Tumbay E
    J Chemother; 2005 Aug; 17(4):404-8. PubMed ID: 16167520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
    Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
    J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichosporon insectorum sp. nov., a new anamorphic basidiomycetous killer yeast.
    Fuentefria AM; Suh SO; Landell MF; Faganello J; Schrank A; Vainstein MH; Blackwell M; Valente P
    Mycol Res; 2008 Jan; 112(Pt 1):93-9. PubMed ID: 18222677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
    Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
    Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of
    Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
    [No Abstract]   [Full Text] [Related]  

  • 39. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
    Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
    Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
    J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.